PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Mar-2022 Lutz Hilbrich Appointed as Senator to the Senate of Economy Europe B3C newswire
07-Mar-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference Vivoryon Therapeutics N.V.
07-Mar-2022 Strong sales growth and further margin improvements – important acquisition to accelerate the US extremities business Medartis Holding AG
05-Mar-2022 Exclusive Chemaxon Interview released - Sponsor at AI in Drug Discovery Conference 2022 SMi Group
04-Mar-2022 CRYOBIOPSY OF THE LUNG PROMISES A HIGH DEGREE OF SAFETY FOR PATIENTS Karl Landsteiner University of Health Sciences
04-Mar-2022 Median Technologies files FDA 513(g) regulatory submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device Median Technologies
04-Mar-2022 Qlucore receives second commercial order for new solution Qlucore
04-Mar-2022 Rezafungin awarded Promising Innovation Medicine (PIM) designation by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of invasive candidiasis Mundipharma and Cidara Therapeutics, Inc.
04-Mar-2022 Novo Nordisk’s Wegovy should successfully overcome supply chain challenges by the end of 2022, says GlobalData Novo Nordisk
04-Mar-2022 2021 financial year: Sharp rise in sales and profits COLTENE Holding AG
03-Mar-2022 OXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US AND EUROPEAN HEALTHCARE INVESTORS IN A PRIVATE EQUITY PLACEMENT Oxurion
03-Mar-2022 Dante Labs announces expansion of its Whole Genome Sequencing test with enhanced and broader offering Dante Labs
03-Mar-2022 Straumann Group supports humanitarian relief efforts in Ukraine Straumann Holding AG
03-Mar-2022 Medios AG: Revenue expectation for 2021 exceeded - Significant growth planned for 2022 Medios AG
03-Mar-2022 Medios AG exceeds revenue and EBT pre1 forecasts for financial year 2021 - Executive Board optimistic for financial year 2022 Medios AG
03-Mar-2022 Sanofi’s Dupixent could potentially change the treatment paradigm for eosinophilic esophagitis, says GlobalData Sanofi
03-Mar-2022 Verona Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update Verona Pharma
03-Mar-2022 Domainex expands analytical chemistry capabilities with over £1M worth of new Waters equipment Sciad Newswire
03-Mar-2022 APONTIS PHARMA reports successful financial year 2021 - Single Pills as growth driver APONTIS PHARMA AG
03-Mar-2022 Spexis achieves first CARB-X milestone for its thanatin derivatives program and receives funding of up to USD 1.9 million to initiate lead optimization Spexis AG